Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss – CNBC

Posted on by
  1. Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss  CNBC
  2. Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial  WSJ
  3. Lyme disease vaccine shows 70 percent efficacy, Pfizer says  The Washington Post
  4. Pfizer’s Lyme vaccine shows efficacy, but misses key statistical hurdle  statnews.com
  5. Pfizer Says Long-Awaited Lyme Vaccine Was Effective in Study  Bloomberg.com
Share
XLinkedInWhatsAppTelegramPinterestReddit

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *